RPC Acquires Peracidin® Product Line
MAPLE GROVE, Minn., Aug. 24, 2026 /PRNewswire/ -- RPC is pleased to announce the successful acquisition of the Peracidin® product line from Angelini Pharma, expanding our portfolio of high-quality peroxyacetic/peracetic acid (PAA) sterilants for dialysis, water treatment and life science...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.